Skip to content

Sexual Functions and Covid-19

Evaluation of Women's Sexual Functions After Having Covid-19

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05018065
Enrollment
101
Registered
2021-08-24
Start date
2020-05-01
Completion date
2020-12-30
Last updated
2021-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Sexual Behavior

Brief summary

Sexual health is one the important components of life quality. The aim of this study is to compare sexual dysfunction of women who survived Covid-19 and who didn't undergo Covid-19.

Detailed description

With identifying a new type of coronavirus, the infection disease known as Coronavirus disease-2019 (Covid-19) is still effective worldwide. Within the frame of the description that the health is a complete physical, mental and social welfare, many physical and mental modality may be expected due to the pandemic and the measures against pandemic. Among them, sexual health is one of the basic indicative factors of human welfare. There are few data on sexual dysfunctions from the previous clinic pandemic experiences. From the very early stages of Covid-19 pandemic, health systems and researches focused on mortalities and short-term morbidities. Although there are similar studies about effects of pandemic on sexual behaviors of general community, there is no comparative study about the effects on sexual functions of women survived from Covid-19 and women having no Covid-19 history, yet. This study aims to compare women survived from Covid-19 and women having no Covid-19 history and having similar characteristics in terms of sexual dysfunctions.

Interventions

BEHAVIORALWomen sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)

sexual dysfunction assesment

Sponsors

Gaziosmanpasa Research and Education Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* previously diagnosed for mild - medium Covid-19 infection and had ambulatory care * being sexually active

Exclusion criteria

* having psychiatric disease * having any malignity * having endometriosis * having a gynecologic surgery history * having a previous sexual dysfunction

Design outcomes

Primary

MeasureTime frameDescription
Sexual function assesment of women previously diagnosed with mild - medium Covid-19 and comparision of results with helath women6 monthsSexual function assesment of women is done by using Female Sexual Functioning Index (FSFI).

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026